Examining Impact of Addiction Medicine Consult Service on MOUD Initiation | ACCP 2024
Research presented at ACCP 2024 found that addiction medicine consult services could help increase medication for opioid use disorder initiation.
Read More
Older Adults with RSV Vaccine Experienced Fewer Infections, Hospitalizations | CHEST 2024
Researchers addressed the prevalence of RSV and its associations with immunization, infection, and hospitalization amongst older adults.
Arexvy Maintains Efficacy Against RSV Over 3 RSV Seasons | CHEST 2024
GSK’s respiratory syncytial virus vaccine continued to provide adults aged 60 years and older with clinically meaningful protection.
Conference Recap: CHEST 2024
This year’s annual meeting of the American College of Chest Physicians featured more than 300 educational sessions, insights from over 600 faculty members, and 29.5 hours of CE credits.
Examining the Impact of COVID-19 on Patients with Liver Disease
Research presented at CHEST 2024 examined outcomes of COVID-19 on patients with alcoholic liver disease, cirrhosis, and non-alcohol steatohepatitis.
Assessing the Efficacy of Mepolizumab in Asthma, COPD
Research Presented at CHEST 2024 reported on how mepolizumab can improve asthma control, and reduce exacerbations of concurrent asthma and COPD.
Prednisone Superior to Other Corticosteroids for Patients with COPD, Heart Failure
Research presented at CHEST 2024 examined the effect of steroid choice on individuals who have a dual diagnosis of heart failure and COPD.
Examining Flu, COVID-19 Infection Outcomes in Children
Research being presented at CHEST 2024 analyzed morbidity and outcomes of children infected with influenza, COVID-19 or both.
Conference Preview: CHEST Annual Meeting 2024
This year’s meeting will take place from October 6 to 9 in Boston, Massachusetts.
Examining Guideline-Directed Medical Therapy in Patients with HFrEF
Several posters presented at the Heart Failure Society of America 2024 Annual Meeting looked into the landscape of guideline-directed medical therapy.
Cocaine, Cannabis Use Significantly Increased Cardiovascular Events
In posters presented at the Heart Failure Society of America 2024 Annual Meeting, researchers assessed how substance use disorders impact cardiovascular outcomes.
Physical Frailty Prominent in Women, Retired or Unemployed Patients with Heart Failure
Among patients with heart failure, researchers aimed to understand the association between social detriments of health and physical frailty.
Statins May Reduce Risk of Complications in Heart Transplant Recipients
Two posters presented at the Heart Failure Society of America 2024 Annual Meeting looked deeper into the topic of statin use in heart transplant recipients.
Diabetic Emergencies Led to Decreased Cardiovascular Events in Patients with Heart Failure
Researchers compared the cardiovascular outcomes of patients hospitalized for heart failure that did or did not experience diabetic emergencies.
Angiotensin Neprilysin Inhibitors Could Benefit Patients with HFrEF
Angiotensin neprilysin inhibitors have shown to reduce the risk of death and hospitalization due to heat failure, but high prescription costs are a current barrier.
Higher Vaccination Rates Improve Outcomes in Heart Failure During Respiratory Virus Season
Vaccination against respiratory viruses such as RSV and the flu are crucial to prevent adverse outcomes in patients with heart failure.
Guideline-Directed Medical Therapy Improves Outcomes in HFrEF
Left ventricular ejection fraction, brain natriuretic peptide, and heart failure-related hospitalizations were among the improved metrics.
Navigating Nephrolithiasis: A Pharmacist's Perspective
Mark Garofoli combined personal anecdotes with professional expertise to deliver a compelling presentation on kidney stone pain at this year’s PAINWeek National Conference.
Q&A: Social Drivers, Access to Care Limit Reach of Pharmacy-Based Diabetes Programs
Addressing the external factors that can have an impact on patient health can make clinical interventions more effective when administered.
Community Pharmacists Can Impact Disparities in Care Delivery, Access
The tools that can be used to reduce health disparities exist, but they must be widely disseminated to populations across the US.
Watch
Q&A: As Scope of Practice Expands, Technology Must Catch Up
Pharmacists can fill a role for patients, but without technology supporting workflows and reimbursement efforts, challenges will remain.
The Future of Electronic Prescribing Can Help Providers, Pharmacists, and Patients Manage Costs
Through Surescripts, pharmacists can cut down on back-and-forth with prescribers’ offices, saving valuable time for patient care.
Interoperability Is Crucial in Sustainable Health Care Models
Pharmacists must be able to view clinical information about patients in order to provide the best clinical care.
Physician Shortage Provides Opportunity for Pharmacists to Step Up
However, reimbursement for these services for pharmacists remains a crucial issue.
Amidst Push for PBM Reform, NACDS Grassroots Efforts Bloom
Inviting members of Congress into the pharmacy helps legislators experience first hand the value that pharmacists bring to their communities.
Video: Legislation, FTC Interim Report Positive Progress in Fight for PBM Reform
Bipartisan support—in a polarized Congress—underscores the importance of pharmacy benefit manager reform.
A Diabetes Intervention in Community Pharmacy Drives Value-Based Health Care
A collaboration with Blue Cross and Blue Shield of North Carolina focused on commercial populations has improved care and lowered costs in the state.
Pharmacy Forecast: GLP-1 Profitability Expected to Remain a Challenge
Both the restructuring of direct and indirect remuneration fees and health care cyber attacks made an impact on the industry in the first half of 2024.
IQVIA: GLP-1 Therapies, Health Care Cyber Attacks Among Top Industry Impacts in 2024
Perhaps unsurprisingly, GLP-1 therapies are expected to continue making headlines within the industry.
Transforming Diabetes Interventions Into Sustainable Programs for Pharmacy
To scale up diabetes intervention programs, sustainable workflows, trainings, and payment models are key.